Dexcom (Nasdaq:DXCM) today unveiled its next-generation continuous glucose monitor (CGM), the G8 system, at its Investor Day ...

Glooko announced that the FDA granted 510(k) clearance for its EndoTool IV Cloud, a cloud-based, patient-specific insulin dosing platform.

Glooko and MyLife Diabetes Care announced today that they agreed to expand their partnership centered around diabetes management products. Under their agreement, Glooko serves as MyLife Diabetes ...

ViCentra announced today that it launched its Kaleido smartphone-controlled hybrid closed-loop insulin delivery system in ...

Tandem Diabetes Care (Nasdaq:TNDM) announced that it made its t:slim X2 insulin pump available with the Dexcom (Nasdaq:DXCM) ...

Insulet (Nasdaq:PODD) today reported first-quarter financial results that came in well ahead of the consensus forecast on ...

Insulet enrolled the first participant in a study of its fully closed-loop automated insulin delivery system for type 2 ...

Glucotrack (Nasdaq:GCTK) announced today that it submitted its implantable continuous blood glucose monitor (CBGM) for FDA ...

Sava Technologies today announced the appointment of John Bernard as its new chief commercial officer (CCO).

Senseonics (NYSE:SENS) today reported first-quarter financial results that exceeded Wall Street's revenue expectations.